204 related articles for article (PubMed ID: 27297691)
1. Prochelator strategies for site-selective activation of metal chelators.
Oliveri V; Vecchio G
J Inorg Biochem; 2016 Sep; 162():31-43. PubMed ID: 27297691
[TBL] [Abstract][Full Text] [Related]
2. Stimulus-Responsive Prochelators for Manipulating Cellular Metals.
Wang Q; Franz KJ
Acc Chem Res; 2016 Nov; 49(11):2468-2477. PubMed ID: 27749047
[TBL] [Abstract][Full Text] [Related]
3. The Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders.
Giampietro R; Spinelli F; Contino M; Colabufo NA
Mol Pharm; 2018 Mar; 15(3):808-820. PubMed ID: 29323501
[TBL] [Abstract][Full Text] [Related]
4. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.
Robert A; Liu Y; Nguyen M; Meunier B
Acc Chem Res; 2015 May; 48(5):1332-9. PubMed ID: 25946460
[TBL] [Abstract][Full Text] [Related]
5. The transition metals copper and iron in neurodegenerative diseases.
Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective Potential of Iron Chelators and Prochelators.
Jansová H; Šimůnek T
Curr Med Chem; 2019; 26(2):288-301. PubMed ID: 28933303
[TBL] [Abstract][Full Text] [Related]
7. Prochelators triggered by hydrogen peroxide provide hexadentate iron coordination to impede oxidative stress.
Leed MG; Wolkow N; Pham DM; Daniel CL; Dunaief JL; Franz KJ
J Inorg Biochem; 2011 Sep; 105(9):1161-72. PubMed ID: 21708101
[TBL] [Abstract][Full Text] [Related]
8. Different approaches to the study of chelating agents for iron and aluminium overload pathologies.
Crisponi G; Dean A; Di Marco V; Lachowicz JI; Nurchi VM; Remelli M; Tapparo A
Anal Bioanal Chem; 2013 Jan; 405(2-3):585-601. PubMed ID: 23096940
[TBL] [Abstract][Full Text] [Related]
9. Iron: effect of overload and deficiency.
Hider RC; Kong X
Met Ions Life Sci; 2013; 13():229-94. PubMed ID: 24470094
[TBL] [Abstract][Full Text] [Related]
10. Influence of chelators and iron ions on the production and degradation of H2O2 by beta-amyloid-copper complexes.
Deraeve C; Pitie M; Meunier B
J Inorg Biochem; 2006 Dec; 100(12):2117-26. PubMed ID: 17011628
[TBL] [Abstract][Full Text] [Related]
11. Importance of iron chelation in free radical-induced oxidative stress and human disease.
Jomova K; Valko M
Curr Pharm Des; 2011; 17(31):3460-73. PubMed ID: 21902663
[TBL] [Abstract][Full Text] [Related]
12. Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.
Zheng H; Youdim MB; Fridkin M
J Med Chem; 2009 Jul; 52(14):4095-8. PubMed ID: 19485411
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
Lanza V; Milardi D; Di Natale G; Pappalardo G
Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
[TBL] [Abstract][Full Text] [Related]
14. Metal ions, Alzheimer's disease and chelation therapy.
Budimir A
Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339
[TBL] [Abstract][Full Text] [Related]
15. Reorganizing metals: the use of chelating compounds as potential therapies for metal-related neurodegenerative disease.
Badrick AC; Jones CE
Curr Top Med Chem; 2011; 11(5):543-52. PubMed ID: 21189128
[TBL] [Abstract][Full Text] [Related]
16. DFT investigation on the selective complexation of Fe
Kaviani S; Izadyar M; Housaindokht MR
J Mol Graph Model; 2018 Mar; 80():182-189. PubMed ID: 29414037
[TBL] [Abstract][Full Text] [Related]
17. Novel double prodrugs of the iron chelator N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED): Synthesis, characterization, and investigation of activation by chemical hydrolysis and oxidation.
Thiele NA; Abboud KA; Sloan KB
Eur J Med Chem; 2016 Aug; 118():193-207. PubMed ID: 27128183
[TBL] [Abstract][Full Text] [Related]
18. The potential application of iron chelators for the treatment of neurodegenerative diseases.
Hider RC; Roy S; Ma YM; Le Kong X; Preston J
Metallomics; 2011 Mar; 3(3):239-49. PubMed ID: 21344071
[TBL] [Abstract][Full Text] [Related]
19. Chelating agents for neurodegenerative diseases.
Ward RJ; Dexter DT; Crichton RR
Curr Med Chem; 2012; 19(17):2760-72. PubMed ID: 22489724
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
